# Tactile Medical Publishes Six-Month RCT Results for Flexitouch Plus in Head and Neck Cancer-Related Lymphedema

> clinical trial · REPORTED · 2026-08-10

Tactile Medical published six-month results from its large randomized controlled trial evaluating Flexitouch Plus for head and neck cancer-related lymphedema, drawn from 236 patients across 10 sites, showing patient-reported outcomes comparable with therapist-guided care. The company also submitted for an expanded FDA indication for its LymphaTech diagnostic tool, with anticipated approval in 2027.

About Tactile Medical: Tactile Medical is a medical technology company that develops and markets at-home advanced pneumatic compression and wearable therapies for patients with lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease.

- Company: Tactile Medical
- Sector: medical devices
- Primary source: https://finance.yahoo.com/healthcare/articles/tactile-systems-technology-q2-earnings-020359740.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.